← Leaderboards
Amanda Randolph
University Of Texas Med Br Galveston
$187,168
Attributed
$187,168
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $42.7K · FY2017–21$50K$37.5K$25K$12.5K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$187,168 · 1
By mechanism
F30$187,168 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Oscar E Suman$6,668,607
- Douglas Paddon-Jones$4,597,752
- Ramkumar Menon$9,581,117
- Soham Al Snih$512,960
- Christopher Sarko$2,588,514
Others in their field
Other Emerging Leaders on “Future”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- John E West · University Of Texas At Austin$128,483,161
- Beth Baseler · Leidos Biomedical Research, Inc.$117,364,154
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
Research focus
FutureHyperglycemiaExercise TrainingFda ApprovedAging PopulationGlycationAge-Related Muscle LossExerciseElderlyAnimalsBaseBiochemicalCharacteristicsChronicClinical TrialsCross-Sectional StudiesCytokineAdvanced Glycosylation End ProductsAnimal ModelAgingDisabilityDrug TargetingEffectivenessImaging Technology
Grant awards (5)
Advanced Glycation End-products, Exercise, and Sarcopenia$35,525
F30 · FY2021 · AG · contact PI
Advanced Glycation End-products, Exercise, and Sarcopenia$42,713
F30 · FY2020 · AG · contact PI
Advanced Glycation End-products, Exercise, and Sarcopenia$41,581
F30 · FY2019 · AG · contact PI
Advanced Glycation End-products, Exercise, and Sarcopenia$33,995
F30 · FY2018 · AG · contact PI
Advanced Glycation End-products, Exercise, and Sarcopenia$33,354
F30 · FY2017 · AG · contact PI